Effect of i.v. tenoxicam during caesarean delivery on platelet activity

Acta Anaesthesiologica Scandinavica

Volumn 44, Issue 5, 2000, Pages 555-559

  Elhakim, Mokhtar ^a,b   Fathy, A ^a   Amine, H ^a   Saeed, A ^a   Mekawy, M ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b Al Horreya Heliopolis   (Egypt)

Author keywords

Analgesic, intravenous: tenoxicam; Anesthesia, obstetric; Beta thromboglobulin ( TG), platelet factor 4 (PF4); Blood loss

Indexed keywords

TENOXICAM;

ADULT; ARTICLE; BLEEDING TENDENCY; BLEEDING TIME; CESAREAN SECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; POSTOPERATIVE PAIN; PRIORITY JOURNAL; THROMBOCYTE FUNCTION;

ADULT; ANESTHESIA, GENERAL; ANESTHESIA, OBSTETRICAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA-THROMBOGLOBULIN; BLEEDING TIME; BLOOD LOSS, SURGICAL; BLOOD PLATELETS; CESAREAN SECTION; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; PAIN, POSTOPERATIVE; PIROXICAM; PLATELET COUNT; PLATELET FACTOR 4; PREGNANCY; UTERUS;

EID: 0034012431     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2000.00512.x     Document Type: Article

References (24)

1. 1. Bush DJ, Lyons G, Macdonald R. Diclofenac for analgesia after caesarean section. Anaesthesia 1992: 47: 1075-1077.
2. 2. Elhakim M, Nafie M. I.v. tenoxicam for analgesia during caesarean section. Br J Anaesth 1995: 74: 643-646.
3. 3. Weiss HJ, Aledort LM, Kochwa S. The effect of salicylates on the hemostatic properties of platelets in man. J Clin Invest 1968: 47: 2169-2180.
4. 4. Rorarius M, Miralles J, Baer GA, Palomaki E. Diclofenac versus indomethacin given as intravenous infusions: Their effect on haemodynamics and bleeding time, and side effects in healthy subjects. Ann Clin Res 1985: 17: 306-309.
5. 5. Schafer AI. The hypercoagulable states. Ann Intern Med 1985: 102: 814-828.
6. 6. Fletcher A, Alkjaersig N, Burstein R. The influence of pregnancy upon blood coagulation and plasma fibrinolytic enzyme function. Am J Obstet Gynecol 1979: 134: 743-751.
7. 7. Kaplan KL, Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981: 57: 199-202.
8. 8. Ivy AC, Nelson D, Bucher G. Standardization of certain factors in the cutaneous venostasis bleeding time technique. J Lab Clin Med 1941: 26: 1812-1822.
9. 9. Mielke CH, Kaneshiro MM, Maher IA, Weiner JM, Rapaport SI. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 1969: 34: 204-215.
10. 10. Walz DA. Platelet-released proteins as molecular markers for the activation process. Semin Thromb Hemostasis 1985: 10: 270-279.
11. 11. Amiral J. Measurement of beta-thromboglobulin and platelet factor-4 with ELISA methods. 10th International congress of thrombosis and hemostasis, San Diego, 1985.
12. 12. Weiss HJ, Aledort LM, Kochwa S. The effect of salicylates on hemostatic properties of platelets in man. J Clin Invest 1968: 47: 2169-2180.
13. 13. Nilsen OG. Clinical pharmacokinetics of tenoxicam. Clin Pharmacokinet 1994: 26: 16-43.
14. 14. Windsor A, McDonald P, Mumtaz T, Millar JM. The analgesic efficacy of tenoxicam versus placebo in day case laparoscopy: a randomized parallel double-blind trial. Anaesthesia 1996: 51: 1066-1069.
15. 15. Rane A, Oelzo O, Frolich JC, Seyberth HW, Sweetman BJ, Watson JT et al. Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man. Clin Pharmacol Ther 1978: 23: 658-668.
16. 16. Gerbasi FR, Bottoms S, Farag A, Mammen E. Increased intravascular coagulation associated with pregnancy. Obstet Gynecol 1990: 75: 385-389.
17. 17. O'Brien WF, Saba HI, Knuppel RA, Scerbo JC, Coben GR. Alterations in platelet concentration and aggregation in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1986: 155: 486-490.
18. 18. Power I, Chambers W, Greer IA, Ramage D, Simon E. Platelet function after intramuscular diclofenac. Anaesthesia 1990: 45: 916-919.
19. 19. Vissinger H, Husted SE, Kristensen SD, Nielsen HK. Platelet-derived growth factor release and antiplatelet treatment with low-dose acetylsalicylic acid. Angiology 1993: 44: 633-638.
20. 20. Kaukinen S, Seppala E, Kaukinen L, Ojanen R, Vapaatalo H. Effects of halothane and enflurane on prostanoid concentration in operation patients. Prostaglandins Leukotrienes Med 1987: 29: 85-94.
21. 21. Rorarius MGF, Baer GA, Metsa-Kettela T, Miralles J, Palomaki E, Vapaatalo H. Effects of preoperatively administered diclofenac and indomethacin on blood loss, bleeding time and plasma prostanoids in man. Eur J Anaesthesiol 1989: 6: 335-342.
22. 22. Cohen SE. Why is the pregnant patient different. In: Hershey SG, Bamforth BJ, Zauder HL, eds. Refresher courses in anesthesiology, vol 11. Philadelphia: J. B. Lippincott Company, 1983: 45-58.
23. 23. Bricker SRW, Savage ME, Hanning CD. Peri-operative blood loss and non-steroidal anti-inflammatory drugs: an investigation using diclofenac in patients undergoing transurethral resection of the prostate. Eur J Anaesthesiol 1987: 4: 429-434.
24. 24. Engel C, Lund B, Kristensen SS, Axel C, Nielsen JB. Indomethacin as an analgesic after hysterectomy. Acta Anaesthesiol Scand 1989: 33: 498-501.